Chesterton Tribune

 

 

Porter Hospital offers new line of therapy to treat totally blocked arteries, first in area to do so

Back To Front Page

The Center for Cardiovascular Medicine at Porter Regional Hospital has recently employed new devices designed to treat fully blocked coronary arteries known as Chronic Total Occlusions (CTOs).

Historically, totally blocked arteries have been addressed by heart bypass surgery or treated with prescription drugs. The first patient of Interventional Cardiologist Keith Atassi, M.D. was treated on June 27 using novel techniques and technology from Boston Scientific, and was released from the hospital the next day.

The Center for Cardiovascular Medicine at Porter Regional Hospital is the first facility in the area to make this new line of therapy available to their patients.

According to multiple studies, 31 percent of patients referred for coronary angiography have at least one totally blocked artery. CTOs affect the survival and quality of life of hundreds of thousands of people, and have historically been an untreatable condition for many patients. While some are treated with bypass surgery, 60 percent of patients with CTOs are treated only with prescription drugs.

The Center for Cardiovascular Medicine at Porter Regional Hospital sees these new devices and techniques as an alternative to medical management and a way to improve the quality of life for its patients with CTOs. The center has established a CTO Program to address this complex form of coronary artery disease, including in-depth physician training from Boston Scientific on the CrossBossª and Stingrayª Coronary CTO Crossing and Re-entry System. These devices enable physicians to treat lesions more successfully and efficiently using minimally invasive techniques. They are currently the only devices of their kind on the market that are FDA cleared to specifically treat coronary CTOs.

“These unique devices require new techniques and training and we are now among a select group of hospitals nationwide to develop these skills with these new devices,” stated Dr. Atassi following the procedure. “Chronic total occlusions used to have limited treatment alternatives beyond medical management or surgery and we are pleased to be able to bring these innovative new devices and additional treatment options to our patients and our community.”

 

 

Posted 7/11/2013